Journal of Gastroenterology

, Volume 44, Issue 11, pp 1133–1139 | Cite as

Decreased production of immunoglobulin M and A in autoimmune pancreatitis

  • Masashi Taguchi
  • Yasuyuki Kihara
  • Yoshikuni Nagashio
  • Mitsuyoshi Yamamoto
  • Makoto Otsuki
  • Masaru Harada
Original Article—Liver, Pancreas, and Biliary Tract

Abstract

Background

Autoimmune pancreatitis (AIP) is a rare type of chronic pancreatitis caused by an autoimmune abnormality. It is well known that high serum concentrations of IgG4 are helpful for making a diagnosis of AIP; however, it is unclear whether there are abnormalities in the production of other immunoglobulins in AIP.

Methods

We examined the immune condition of AIP patients before and after glucocorticoid treatment, focusing on serum levels of IgG, IgG4, IgM and IgA, and compared the results with those in other hepato-pancreatic diseases, such as autoimmune hepatitis, primary biliary cirrhosis, chronic pancreatitis and pancreatic carcinoma.

Results

IgM and IgA were decreased in patients with untreated AIP. IgM and IgG or IgG4 were negatively correlated in patients with AIP. The ratios of IgG to IgM and IgG to IgA in patients with AIP were significantly increased compared with the other diseases. The diagnostic sensitivity of IgG to IgM and IgG to IgA was 0.800 and 0.950, and the specificity of each ratio was 0.703 and 0.728, respectively, in the differentiation of AIP from the other diseases. IgM was not significantly changed after glucocorticoid treatment in the patients with AIP, while IgG, IgG4 and IgA decreased.

Conclusions

The ratios of IgG to IgM and IgG to IgA may serve as novel diagnostic markers to differentiate AIP from other hepato-pancreatic diseases. Furthermore, low concentrations of IgM and IgA may be involved in the pathogenesis of AIP.

Keywords

Autoimmune pancreatitis Immunodeficiency Immunoglobulin A Immunoglobulin G Immunoglobulin M 

References

  1. 1.
    Otsuki M. Chronic pancreatitis in Japan: epidemiology, prognosis, diagnostic criteria, and future problems. J Gastroenterol. 2003;38:315–26.CrossRefPubMedGoogle Scholar
  2. 2.
    Otsuki M. Chronic pancreatitis. The problems of diagnostic criteria. Pancreatology. 2004;4:28–41.CrossRefPubMedGoogle Scholar
  3. 3.
    Steer ML, Waxman I, Freedman S. Chronic pancreatitis. N Engl J Med. 1995;332:1482–90.CrossRefPubMedGoogle Scholar
  4. 4.
    Whitcomb DC. Mechanisms of disease: advances in understanding the mechanisms leading to chronic pancreatitis. Nat Clin Pract Gastroenterol Hepatol. 2004;1:46–52.CrossRefPubMedGoogle Scholar
  5. 5.
    Yoshida K, Toki F, Takeuchi T, Watanabe S, Shiratori K, Hayashi N. Chronic pancreatitis caused by an autoimmune abnormality. Proposal of the concept of autoimmune pancreatitis. Dig Dis Sci. 1995;40:1561–8.CrossRefPubMedGoogle Scholar
  6. 6.
    Hamano H, Kawa S, Horiuchi A, Unno H, Furuya N, Akamatsu T, et al. High serum IgG4 concentrations in patients with sclerosing pancreatitis. N Engl J Med. 2001;344:732–8.CrossRefPubMedGoogle Scholar
  7. 7.
    Kamisawa T, Funata N, Hayashi Y, Tsuruta K, Okamoto A, Amemiya K, et al. Close relationship between autoimmune pancreatitis and multifocal fibrosclerosis. Gut. 2003;52:683–7.CrossRefPubMedGoogle Scholar
  8. 8.
    Okazaki K, Chiba T. Autoimmune related pancreatitis. Gut. 2002;51:1–4.CrossRefPubMedGoogle Scholar
  9. 9.
    Okazaki K, Uchida K, Fukui T. Recent advances in autoimmune pancreatitis: concept, diagnosis, and pathogenesis. J Gastroenterol. 2008;43:409–18.CrossRefPubMedGoogle Scholar
  10. 10.
    Okazaki K, Kawa S, Kamisawa T, Naruse S, Tanaka S, Nishimori I, et al. Clinical diagnostic criteria of autoimmune pancreatitis: revised proposal. J Gastroenterol. 2006;41:626–31.CrossRefPubMedGoogle Scholar
  11. 11.
    Alvarez F, Berg PA, Bianchi FB, Bianchi L, Burroughs AK, Cancado EL, et al. International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis. J Hepatol. 1999;31:929–38.CrossRefPubMedGoogle Scholar
  12. 12.
    Heathcote EJ. Management of primary biliary cirrhosis. The American Association for the Study of Liver Diseases practice guidelines. Hepatology. 2000;31:1005–13.CrossRefPubMedGoogle Scholar
  13. 13.
    Goldstein MF, Goldstein AL, Dunsky EH, Dvorin DJ, Belecanech GA. Shamir K Selective IgM immunodeficiency: retrospective analysis of 36 adult patients with review of the literature. Ann Allergy Asthma Immunol. 2006;97:717–30.PubMedGoogle Scholar
  14. 14.
    Chandra RK, Kaveramma B, Soothill JF. Generalised non-progressive vaccinia associated with IgM deficiency. Lancet. 1969;1:687–9.CrossRefPubMedGoogle Scholar
  15. 15.
    Hobbs JR. IgM deficiency. Birth Defects Orig Artic Ser. 1975;11:112–6.PubMedGoogle Scholar
  16. 16.
    Blecher TE, Brzechwa-Ajdukiewicz A, McCarthy CF, Read AE. Serum immunoglobulins and lymphocyte transformation studies in coeliac disease. Gut. 1969;10:57–62.CrossRefPubMedGoogle Scholar
  17. 17.
    Kimura S, Tanigawa M, Nakahashi Y, Inoue M, Yamamura Y, Kato H, et al. Selective IgM deficiency in a patient with Hashimoto’s disease. Intern Med. 1993;32:302–7.CrossRefPubMedGoogle Scholar
  18. 18.
    Komatsu K, Hamano H, Ochi Y, Takayama M, Muraki T, Yoshizawa K, et al. High prevalence of hypothyroidism in patients with autoimmune pancreatitis. Dig Dis Sci. 2005;50:1052–7.CrossRefPubMedGoogle Scholar
  19. 19.
    Raziuddin S, Danial HB, Kelley M. OKT4+ T cell abnormality in patients with active systemic lupus erythematosus: HLA-DR antigen expressions. Clin Immunol Immunopathol. 1988;48:42–9.CrossRefPubMedGoogle Scholar
  20. 20.
    Takeuchi T, Nakagawa T, Maeda Y, Hirano S, Sasaki-Hayashi M, Makino S, et al. Functional defect of B lymphocytes in a patient with selective IgM deficiency associated with systemic lupus erythematosus. Autoimmunity. 2001;34:115–22.PubMedCrossRefGoogle Scholar
  21. 21.
    Boes M, Schmidt T, Linkemann K, Beaudette BC, Marshak-Rothstein A, Chen J. Accelerated development of IgG autoantibodies and autoimmune disease in the absence of secreted IgM. Proc Natl Acad Sci USA. 2000;97:1184–9.CrossRefPubMedGoogle Scholar
  22. 22.
    Botto M, Dell’Agnola C, Bygrave AE, Thompson EM, Cook HT, Petry F, et al. Homozygous C1q deficiency causes glomerulonephritis associated with multiple apoptotic bodies. Nat Genet. 1998;19:56–9.CrossRefPubMedGoogle Scholar
  23. 23.
    Muraki T, Hamano H, Ochi Y, Komatsu K, Komiyama Y, Arakura N, et al. Autoimmune pancreatitis and complement activation system. Pancreas. 2006;32:16–21.CrossRefPubMedGoogle Scholar
  24. 24.
    Mestecky J, Russell MW, Elson CO. Intestinal IgA: novel views on its function in the defence of the largest mucosal surface. Gut. 1999;44:2–5.PubMedCrossRefGoogle Scholar
  25. 25.
    Jacob CM, Pastorino AC, Fahl K, Carneiro-Sampaio M, Monteiro RC. Autoimmunity in IgA deficiency: revisiting the role of IgA as a silent housekeeper. J Clin Immunol. 2008;28(Suppl 1):S56–61.CrossRefPubMedGoogle Scholar
  26. 26.
    Carneiro-Sampaio M, Coutinho A. Tolerance and autoimmunity: lessons at the bedside of primary immunodeficiencies. Adv Immunol. 2007;95:51–82.CrossRefPubMedGoogle Scholar
  27. 27.
    Goldstein MF, Goldstein AL, Dunsky EH, Dvorin DJ, Belecanech GA, Shamir K. Pediatric selective IgM immunodeficiency. Clin Dev Immunol. 2008;2008:624850.PubMedGoogle Scholar
  28. 28.
    Hammarstrom L, Vorechovsky I, Webster D. Selective IgA deficiency (SIgAD) and common variable immunodeficiency (CVID). Clin Exp Immunol. 2000;120:225–31.CrossRefPubMedGoogle Scholar
  29. 29.
    Rhen T, Cidlowski JA. Antiinflammatory action of glucocorticoids new mechanisms for old drugs. N Engl J Med. 2005;353:1711–23.CrossRefPubMedGoogle Scholar

Copyright information

© Springer 2009

Authors and Affiliations

  • Masashi Taguchi
    • 1
  • Yasuyuki Kihara
    • 1
  • Yoshikuni Nagashio
    • 1
  • Mitsuyoshi Yamamoto
    • 1
  • Makoto Otsuki
    • 1
  • Masaru Harada
    • 1
  1. 1.Third Department of Internal MedicineUniversity of Occupational and Environmental Health, Japan School of MedicineKitakyushuJapan

Personalised recommendations